RYAN DAVIS: Open Payments
NPI 1639823362 · BOUNTIFUL, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,592 in 101 payments from 25 companies in 2025. Trend: 2023 $833 · 2024 $1,753 · 2025 $1,592
Food & beverage: $1,592
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $316 |
| ABBVIE INC. | 21 | $253 |
| Lilly USA, LLC | 17 | $191 |
| Astellas Pharma US Inc | 6 | $98 |
| AstraZeneca Pharmaceuticals LP | 5 | $94 |
| Novartis Pharmaceuticals Corporation | 5 | $91 |
| Otsuka America Pharmaceutical, Inc. | 5 | $79 |
| Janssen Pharmaceuticals, Inc | 2 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $46 |
Products named: EVENITY, QULIPTA, MOUNJARO, OTEZLA, VRAYLAR, Veozah, REXULTI, LEQVIO.
Industry payments across UT — which companies pay providers there.
